WeVote
Log In

Bill

Bill

HB 1288

Ivermectin; authorize pharmacists to provide to adults pursuant to collaborative pharmacy practice agreement.

2025 Regular Session Introduced by Carolyn Crawford

Bill would allow Mississippi pharmacists to dispense ivermectin to adults independently via collaborative agreements, potentially without physician oversight or clinical criteria specifications.

Died In Committee
#publichealthandhumanservices
0
WeVote Research Nonpartisan
Bill Summary · HB 1288

Legislative bill overview

HB 1288 would authorize Mississippi pharmacists to dispense ivermectin to adults under a collaborative pharmacy practice agreement without requiring a physician prescription. The bill establishes a framework allowing pharmacists to independently provide this antiparasitic medication based on established protocols with healthcare providers.

Why is this important

This bill touches on ongoing debates about ivermectin's appropriate use, pharmacy scope of practice, and access to medications. It reflects national discussions about expanding pharmacist authority while raising questions about oversight mechanisms for a drug that has faced significant controversy regarding off-label applications.

Potential points of contention

  • Oversight concerns: The bill lacks specifics on clinical criteria, dosing limits, or monitoring requirements that would govern pharmacist dispensing, raising safety and quality control questions
  • Off-label use controversy: Ivermectin gained notoriety as an unproven COVID-19 treatment; this bill could enable prescribing for unapproved uses despite FDA guidance against such applications
  • Collaborative agreement specifics: The "collaborative pharmacy practice agreement" framework is undefined in the bill summary, leaving unclear what physician oversight or accountability measures would actually exist

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.